FIGURE

Fig. 5

ID

ZDB-FIG-240729-123

Publication

Adekiya et al., 2024 - PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer

Other Figures

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

All Figure Page

Back to All Figure Page

Fig. 5

Mean body weight-time profile of mice treated with brusatol (5 mg/kg and 10 mg/kg), docetaxel (13.5 mg/kg and 27 mg/kg), PSMA-targeted docetaxel-loaded nanoparticles (13.5 mg/kg and 27 mg/kg), PSMA-targeted brusatol-loaded nanoparticles (5 mg/kg and 10 mg/kg), and the controls (PBS and blank-PSMA targeted-nanoparticles) following tail vein injection (n = 3).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed. Pharmacother.